Table of Contents

Topic Summary

  1. Dubai's Population Growth Fuels Cord Blood Demand

    Dubai's population exceeds 3.6 million and is projected to reach 5.8 million by 2040, creating a steadily expanding patient base for specialist cord blood services. Mandatory health insurance further strengthens consistent demand across both insurance-funded and self-pay revenue streams.

  2. Meydan Free Zone Offers Key Business Advantages

    Setting up through Meydan Free Zone gives operators 100% foreign ownership, zero corporate tax on qualifying income, and full profit repatriation. The fully digital licensing process makes market entry faster and more cost-effective compared to many alternative routes.

  3. Know Exactly What Activity Code 8690.87 Covers

    This activity code authorises umbilical cord blood collection at delivery, stem cell processing, cryopreservation, and long-term storage under DHA standards. It also extends to outpatient consultations, preventive screening, follow-up care, and corporate wellness programmes.

  4. Third-Party Approval Is a Required Step

    Before a trade licence is issued, your facility, clinical model, staffing, and regulatory documentation must be reviewed and cleared by the relevant authority. Building this approval process into your timeline from the outset avoids costly delays.

  5. Clear Boundaries Define Who This Licence Suits

    The cord blood centre licence does not cover hospital inpatient services, general medical practice, or unlicensed wellness operations. Operators running a dedicated, licensed cord blood facility are squarely within scope, while broader healthcare providers must use separate activity codes.

  6. Healthcare Is a UAE Strategic National Priority

    The UAE's We the UAE 2031 vision sets explicit targets for healthcare capacity expansion, quality improvement, and medical tourism growth. This policy backing provides long-term regulatory stability and commercial opportunity for licensed specialist operators entering the market.

How to Start a Cord Blood Centre Business in Dubai with Meydan Free Zone

A cord blood centre, the licensed facility providing specialist umbilical cord blood collection at delivery services, serves a growing patient and consumer base in Dubai.¹

Dubai's population of over 3.6 million, projected to reach 5.8 million by 2040,³ combined with mandatory health insurance and a strong wellness positioning, drives demand for licensed cord blood centre services.

For operators, a cord blood centre benefits from specialist positioning, insurance and self-pay revenue streams, and DHA regulatory clarity.²

That sustained demand for quality healthcare, specialist capacity, and population growth is exactly where the opportunity lies.

Insight and Data about Cord Blood Banking in Dubai: Birth Rate, Stem Cell Demand, and Family Health

Sources: Dubai Health Authority. Strategic Plan and Healthcare Statistics, UAE Ministry of Health and Prevention. National Health Strategy, Dubai Media Office, Dubai 2040 Urban Master Plan launch

The UAE has positioned healthcare as a strategic priority under We the UAE 2031, with explicit targets for capacity expansion, quality, Emiratisation, and medical tourism.

Who is this for?

Audience SegmentProfile
Healthcare investorsGroups deploying capital into specialist health services in Dubai, targeting insurance-funded, self-pay, and government-referred patient flows.
Clinical foundersPhysicians, therapists, and healthcare professionals establishing a licensed specialist practice or centre in Dubai.
International health brandsGlobal healthcare and wellness brands establishing a licensed Dubai operation or franchise.

Setting up through Meydan Free Zone means 100% foreign ownership, zero corporate tax on qualifying income, full profit repatriation, and a fully digital licensing process, giving you a fast and cost-effective route into the Dubai market.

8690.87 - Cord Blood Center

Under this activity, you are in the business of operating a licensed cord blood centre providing umbilical cord blood collection at delivery, stem cell processing, cryopreservation, and long-term storage services.

Services are delivered under DHA licensing and quality standards, with qualified practitioners and appropriate clinical or operational infrastructure.¹

CategoryScope
Specialist ConsultationAssessment. Outpatient consultation, assessment, and treatment planning within cord blood centre.
Core TreatmentPrimary services. Umbilical cord blood collection at delivery and related core treatment services.
Ongoing ManagementFollow-up care. Multi-session treatment plans and chronic or recurring condition management.
Preventive ServicesScreening and prevention. Preventive screening, early detection, and wellness services within cord blood centre.
Corporate and GroupB2B services. Corporate wellness, group programmes, and institutional service contracts.

There are some things this activity does not cover. Hospital inpatient services and general medical practice fall under separate codes.

Services outside the defined scope of cord blood centre are classified under their respective activity codes.

In short: if you are operating a licensed cord blood centre, you are in. If you are running a hospital, a general practice, or an unlicensed wellness service, you are not.

Third-Party Approval

This business activity requires third-party approval before the trade licence is issued. In practice, your facility, clinical or operational model, staffing, and regulatory documentation must be reviewed and cleared by the relevant authority before licensing.

Anti-Money Laundering Compliance

This business activity is exempt from AML compliance requirements.

References

  1. ¹ Dubai Health Authority. Strategic Plan and Healthcare Statistics
  2. ² UAE Ministry of Health and Prevention. National Health Strategy
  3. ³ Dubai Media Office, Dubai 2040 Urban Master Plan launch